Atlas Trials

Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo

Clinical trial NCT05233735 · UNKNOWN

Trial details

NCT number
NCT05233735
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Vitiligo
Start date
2021-01-01
Primary completion
2023-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.